Jean-Philippe Lafrance1, Donald R Miller. 1. Center for Health Quality, Outcomes, and Economic Research, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA 01730, USA. jplaf@bu.edu
Abstract
PURPOSE: Use of non-steroidal anti-inflammatory drugs (NSAID) is associated with risk of acute kidney injury (AKI). Risk of AKI may vary with selectivity of the NSAID, but this has not been studied in a large cohort where AKI was assessed directly from laboratory data. The objective was to compare AKI risk between selective and non-selective NSAIDs using a laboratory-based definition of AKI. METHODS: We conducted a retrospective nested case-control study in the U.S. Department of Veterans Affairs health care system. From a cohort of 1 459 271 new NSAID users, we identified 22 824 cases of AKI (97% male; mean age: 63 years), and 336 734 matched controls between 2000 and 2006. AKI was defined as a creatinine increase of greater than 50%. RESULTS: We found higher risk of AKI in new users of any single NSAID (adjusted odds ratio = 1.82; 95%CI: 1.68, 1.98) compared to non-users without recent use. The risk of AKI varied among different NSAIDs with risk generally increasing with decrease in selectivity: rofecoxib (0.95; 0.64, 1.42), celecoxib (0.96; 0.63, 1.47), meloxicam (1.13; 0.63, 2.05), etodolac (1.31; 1.08, 1.59), diclofenac (1.11; 0.84, 1.48), piroxicam (1.53; 1.05, 2.23), salsalate (1.51; 1.22, 1.87), sulindac (1.61; 1.12, 2.30), ibuprofen (2.25, 2.04, 2.49), naproxen (1.72; 1.52, 1.95), high dose aspirin (3.64; 2.46, 5.37), indomethacin (1.94; 1.56, 2.42), keterolac (2.07; 1.78, 2.41). Those using multiple NSAIDs appeared to have higher risk (2.90; 2.62, 3.22). CONCLUSIONS: This study provides evidence that risk of AKI may be lower with more selective agents than with naproxen or other non-selective NSAIDs. 2009 John Wiley & Sons, Ltd.
PURPOSE: Use of non-steroidal anti-inflammatory drugs (NSAID) is associated with risk of acute kidney injury (AKI). Risk of AKI may vary with selectivity of the NSAID, but this has not been studied in a large cohort where AKI was assessed directly from laboratory data. The objective was to compare AKI risk between selective and non-selective NSAIDs using a laboratory-based definition of AKI. METHODS: We conducted a retrospective nested case-control study in the U.S. Department of Veterans Affairs health care system. From a cohort of 1 459 271 new NSAID users, we identified 22 824 cases of AKI (97% male; mean age: 63 years), and 336 734 matched controls between 2000 and 2006. AKI was defined as a creatinine increase of greater than 50%. RESULTS: We found higher risk of AKI in new users of any single NSAID (adjusted odds ratio = 1.82; 95%CI: 1.68, 1.98) compared to non-users without recent use. The risk of AKI varied among different NSAIDs with risk generally increasing with decrease in selectivity: rofecoxib (0.95; 0.64, 1.42), celecoxib (0.96; 0.63, 1.47), meloxicam (1.13; 0.63, 2.05), etodolac (1.31; 1.08, 1.59), diclofenac (1.11; 0.84, 1.48), piroxicam (1.53; 1.05, 2.23), salsalate (1.51; 1.22, 1.87), sulindac (1.61; 1.12, 2.30), ibuprofen (2.25, 2.04, 2.49), naproxen (1.72; 1.52, 1.95), high dose aspirin (3.64; 2.46, 5.37), indomethacin (1.94; 1.56, 2.42), keterolac (2.07; 1.78, 2.41). Those using multiple NSAIDs appeared to have higher risk (2.90; 2.62, 3.22). CONCLUSIONS: This study provides evidence that risk of AKI may be lower with more selective agents than with naproxen or other non-selective NSAIDs. 2009 John Wiley & Sons, Ltd.
Authors: Ninad Salastekar; Tanvi Desai; Thomas Hauser; Ernst J Schaefer; Kristen Fowler; Stacey Joseph; Steven E Shoelson; Allison B Goldfine Journal: Diabetes Obes Metab Date: 2017-07-06 Impact factor: 6.577
Authors: Allison B Goldfine; Vivian Fonseca; Kathleen A Jablonski; Yii-Der Ida Chen; Laura Tipton; Myrlene A Staten; Steven E Shoelson Journal: Ann Intern Med Date: 2013-07-02 Impact factor: 25.391
Authors: Gabrielle E Hatton; Cynthia Bell; Shuyan Wei; Charles E Wade; Lillian S Kao; John A Harvin Journal: J Trauma Acute Care Surg Date: 2020-10 Impact factor: 3.697
Authors: Eva Gottfried; Sven A Lang; Kathrin Renner; Anja Bosserhoff; Wolfram Gronwald; Michael Rehli; Sabine Einhell; Isabel Gedig; Katrin Singer; Anton Seilbeck; Andreas Mackensen; Oliver Grauer; Peter Hau; Katja Dettmer; Reinhard Andreesen; Peter J Oefner; Marina Kreutz Journal: PLoS One Date: 2013-07-09 Impact factor: 3.240